Bid Banana
PricingBid helpAPILog inStart free trial
Log inStart free trial

Learn more

  • Federal grantsHow to Find Grants for Nonprofits
  • Healthcare RFPsHealthcare and Medical Services Bids and Bidding Guide
  • How to apply for a grantGrant Applications vs. RFPs: Writing Differences Explained
More healthcare and medical services bids →Must-win bid? Bring in The Bid Lab →
Bid Banana
SearchPricingBid helpBrowse bidsAPISupportFAQPrivacy PolicyTerms of UseAI Use Policy

This website and its content is copyright of The Bid Lab © 2026. The Bid Lab is a trademark of Bid Lab, LLC. All rights reserved.

  1. Bid Banana
  2. ›Closed bids
  3. ›Federal
  4. ›NCI Community Oncology Research Program (NCORP) Academic…

U.S. National Institutes of Health·United States of America

NCI Community Oncology Research Program (NCORP) Academic Community Sites (UG1 Clinical Trials Not Allowed)

Closes 9/18/2026$1M – $2MGrants Notice
Bid source

This opportunity has closed.

Bid Banana tracks 1.6M+ bids and awards across all 50 states. Save a search and we'll email your new matches, daily or weekly — so the next one reaches you with time to bid.

Get alerted next time

Description

The National Cancer Institute (NCI) is soliciting applications for the NCI Community Oncology Research Program (NCORP) Academic Community Sites. The purpose of NCORP is to engage cancer patient populations, those at risk of cancer, and organizations in rigorous studies focused on cancer control, prevention, treatment, and care delivery. NCORP Academic Community Sites are consortia of community hospitals and/or oncology practices, a public hospital, and an academic medical center that serves a patient population that can enhance the representativeness of participants accrued to cancer control, prevention, treatment, and care delivery clinical trials and other human subjects research. Key aspects of the job include: * Oversight and accrual at the Academic NCORP Site on NCTN and NCORP clinical trials * Compliance with NCORP Program Guidelines/Handbook * Attendance at Annual NCORP meeting and active participation in Research Base committees and meetings * Collaboration with NIH staff to manage major issues associated with participating in the conduct of trials across the Network

Attached files

Contact

Brandy Heckman-Stoddard(Director)

[email protected]

(240) 276-7048

Key dates

Opened
5/28/2025
Closes
9/18/2026
Projected award
8/1/2026
Duration
4 years

Last updated

Details

Type
Grants Notice
Industry
Healthcare and Medical Services
NAICS
621111
Solicitation №
RFA-CA-27-008

Budget estimate

$1,000,000 – $2,000,000

The estimated funding for this opportunity is $73,000,000, and the number of awards is 50. Assuming an equal distribution of funds, the estimated budget per award would be approximately $1,460,000. However, the actual budget may vary depending on the specific proposal and the evaluation of the application. The factors that may influence the likely payment range include the scope of work, the number of participants, and the duration of the project.

AI estimate from the solicitation

Similar opportunities

Matched by Bid Banana AI™

Bid Banana · 1.6M+ bids and awards 🍌

You found this one too late. Don't find the next one too late.

Bid Banana searches open government bids across all 50 states, updated daily. Save a search once and we email you your new matches, daily or weekly, while there is still time to win them.

1.6M+
bids & awards
All 50
states
4,000+
agencies
Start your 7-day free trial

Plans from $49.99/month. Cancel anytime, no setup fees.

Built by The Bid Lab, answering RFPs since 2017.

U.S. National Institutes of Health·United States of America

Top match · 77%

Research Opportunities in Cancer Epidemiology Cohort Studies (U01 Clinical Trial Not Allowed)

Closes 7/5/2029Opened 6/16/2025

U.S. National Institutes of Health·United States of America

76% match

Cancer Prevention and Control Clinical Trials Grant Program (R01 Clinical Trial Required)

Closes 1/7/2027Opened 12/15/2023

U.S. National Institutes of Health·United States of America

75% match

Cancer Center Support Grants (CCSGs) for NCI-designated Cancer Centers (P30 Clinical Trial Optional)

Closes 9/25/2028Opened 11/26/2025

U.S. National Institutes of Health·United States of America

74% match

Carcinogen Hazard Assessment Monographs Program (CHAMP) (R01 Clinical Trial Not Allowed)

Closes 2/9/2027Opened 11/21/2025

U.S. National Institutes of Health·United States of America

74% match

Cancer Center Support Grants (CCSGs) for NCI-designated Cancer Centers (P30 Clinical Trial Optional)

Closes 1/24/2027Opened 3/10/2026

U.S. National Institutes of Health·United States of America

73% match

National Cancer Institute's Investigator-Initiated Early Phase Clinical Trials for Cancer Treatment and Diagnosis (R01 Clinical Trial Required)

Closes 1/7/2027Opened 12/15/2023

U.S. National Institutes of Health·United States of America

73% match

Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)

Closes 6/3/2027Opened 7/14/2026

U.S. National Institutes of Health·United States of America

73% match

Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)

Closes 11/10/2026Opened 9/8/2025

U.S. National Institutes of Health·United States of America

73% match

Integration of Imaging and Fluid-Based Tumor Monitoring in Cancer Therapy (R01 Clinical Trial Optional)

Closes 1/7/2028Opened 11/6/2024

U.S. National Institutes of Health·United States of America

73% match

NCI Pathway to Independence Award (K99/R00 Clinical Trial Not Allowed)

Closes 10/14/2027Opened 11/20/2024

U.S. National Institutes of Health·United States of America

73% match

Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)

Closes 6/3/2027Opened 7/14/2026

U.S. National Institutes of Health·United States of America

72% match

Cancer Prevention and Control Clinical Trials Planning Grant Program (U34 Clinical Trials Optional)

Closes 10/25/2027Opened 6/23/2022

U.S. National Institutes of Health·United States of America

72% match

Development of Collaborative Research Facilities or Research-Resource Facilities (C06 Clinical Trial Not Allowed)

Closes 1/25/2028Opened 6/17/2025

U.S. National Institutes of Health·United States of America

72% match

NIH Research Program Projects (Parent P01 Clinical Trial Optional)

Closes 5/25/2029Opened 2/11/2026

U.S. National Institutes of Health·United States of America

72% match

Single Source: Coordinating Center (CC) for the Small Cell Lung Cancer (SCLC) Consortium (U24 Clinical Trial Not Allowed)

Closes 1/24/2027Opened 3/24/2026

U.S. National Institutes of Health·United States of America

72% match

Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)

Closes 11/10/2026Opened 9/8/2025

U.S. National Institutes of Health·United States of America

72% match

Specialized Programs of Research Excellence (SPOREs) in Human Cancers for Years 2027, 2028, and 2029 (P50 Clinical Trial Required)

Closes 9/25/2029Opened 9/9/2025

U.S. National Institutes of Health·United States of America

71% match

NCI Research Specialist (Clinician Scientist) Award (R50 Clinical Trial Not Allowed)

Closes 11/1/2026Opened 5/6/2026

U.S. National Institutes of Health·United States of America

71% match

Academic-Industrial Partnerships for Translation of Technologies for Diagnosis and Treatment (R01 - Clinical Trial Optional)

Closes 1/7/2028Opened 3/25/2021

U.S. National Institutes of Health·United States of America

71% match

NIH Research Project Grant (Parent R01 Clinical Trial Not Allowed)

Closes 1/7/2028Opened 5/5/2020

U.S. National Institutes of Health·United States of America

71% match

Genomic Community Resources (U24 Clinical Trials Not Allowed)

Closes 1/24/2027Opened 2/9/2026

U.S. National Institutes of Health·United States of America

71% match

NIH Brain Development Cohorts (NBDC) and�Population Assessment of Tobacco and Health (PATH) Study�Biospecimen Access (X01 Clinical Trial Not Allowed)

Closes 4/17/2029Opened 9/10/2025

U.S. National Institutes of Health·United States of America

71% match

Tobacco Centers of Regulatory Science (TCORS) (Clinical Trial Optional)

Closes 11/9/2027Opened 7/9/2026

U.S. National Institutes of Health·United States of America

71% match

Toward Translation of Nanotechnology Cancer Interventions (TTNCI; R01 Clinical Trial Not Allowed)

Closes 11/15/2027Opened 12/16/2024

U.S. National Institutes of Health·United States of America

70% match

Early-Onset Cancers: Investigating Etiology, Mechanisms, and Early Detection Strategies (RP1 Clinical Trials Optional)

Closes 10/11/2029Opened 3/10/2026